March 2026

The March 2026 newsletter features updates on ARLG studies, new publications, and a clinical trial site spotlight on Mayo Clinic. The newsletter also includes two new member spotlights on Heather Cross, Director of the ARLG Clinical Operations Center and Associate Director of the ARLG Scientific Leadership Center, and Robin Patel, Director of the ARLG Laboratory Center.

December 2025

The December 2025 newsletter features updates on the PHAGE and DOTS (Dalbavancin as an an Option for Treatment of Staphylococcus aureus bacteremia) studies as well as a clinical trial site spotlight on the University of North Carolina. The newsletter also includes a mentee spotlight, study milestones, recent publications, and more ARLG network news.

July 2025

The July 2025 newsletter introduces our new Spotlight on Clinical Sites and highlights many ways the ARLG is working to combat the antibacterial resistance crisis and improve patient care. This edition of the newsletter also includes ARLG member and mentee spotlights, study milestones, new publications, and more.

October 2024

The October 2024 newsletter features exciting highlights from IDWeek 2024, including Dr. Roach winning Innovator of the Year at the IDea Incubator competition, Drs. Tamma and Hanson receiving awards for their contributions to the field of infectious diseases, and Dr. Bonomo delivering the Maxwell Finland Lecture. Read on for exciting study milestones, new publications, member spotlights, and more!

April 2024

The April 2024 newsletter features the announcement of a global partnership formed to combat antibacterial resistance, a new appointment for ARLG member Eli Perencevich, MD, MS, exciting GENO-STELLARTM news, ARLG posters and sessions at ECCMID 2024, member spotlights, and more!

October 2023

The October 2023 newsletter features Dr. Michael Woodworth, MD, MSc, recipient of the Emory University Silver Pear Mentoring Award, as well as Tori Kinamon’s spotlight in the BBC StoryWorks film “Race Against Resistance.” Dive into the DOTS study’s enrollment achievement, ARLG’s partnership with Biomeme on the RADICAL 501k study, and the SHREC study’s summary of results.